Montelukast
Montelukast is a pharmaceutical drug with 150 clinical trials. Currently 16 active trials ongoing. Historical success rate of 92.5%.
Success Metrics
Based on 99 completed trials
Phase Distribution
Phase Distribution
19
Early Stage
35
Mid Stage
74
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.0%
99 of 110 finished
10.0%
11 ended early
16
trials recruiting
150
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes
Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes
Clinical Trials (150)
Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes
Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)
SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes
Does Montelukast Decrease Post Adenotonsillectomy Pain in Children
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
Montelukast in Parkinson Disease
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
Efficacy of Montelukast on STEMl Patients
A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
ACTIV-6: COVID-19 Study of Repurposed Medications
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 150